« Previous
Next »
Annals of Emergency Medicine
Volume 40, Issue 6
, Pages 619-624
, December 2002
Crotalidae polyvalent immune fab (ovine) antivenom is efficacious for envenomations by southern pacific rattlesnakes (Crotalus helleri )
References
-
CroFab, Crotalidae Polyvalent Immune Fab (Ovine) [package insert]. Nashville, TN: Protherics, Inc; 2000;
-
Douglas ME, Douglas MR, Schuett GW, et al. Phylogeography of the western rattlesnake (Crotalus viridis ) complex, with emphasis on the Colorado Plateau. In: Schuett GW, Hoggren M, Douglas ME, et al, eds. Biology of the Vipers . Eagle Mountain, UT: Eagle Mountain Publishing, LC. In press.
- Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg. 1995;53:507–510
- Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med. 1997;30:54–57
-
.
The rattlesnakes and their venom yield and lethal toxicity.
In:
Tu AT editors.
Rattlesnake Venoms: Their Actions and Treatment. New York, NY: Marcel Dekker, Inc; 1982;p. 3–119
- A randomized multicenter trial of crotaline polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030–2036
- . Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001;37:196–201
- Validation of a severity score for the assessment of crotalid snakebite in the United States. Ann Emerg Med. 1996;27:321–326
- Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39
-
.
Snake Species of the World: A Taxonomic and Geographic Reference. Vol. 1. Washington, DC: The Herpetologists' League; 1999;
-
CroFab for treatment of rattlesnake envenomation [abstract].
J Toxicol Clin Toxicol. 2001;39:546–547
- . Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med. 2001;37:189–195
☆ Dr.Bush is a paid participant in an advisory panel for Savage Laboratories, Melville, NY.
☆☆ Address for reprints: Sean P. Bush, MD, 11234 Anderson Street, PO Box 2000, Room A108, Loma Linda, CA 92354; 909-558-4344, fax 909-558-0121; E-mail famensean@aol.com
PII: S0196-0644(02)00660-1
doi: 10.1067/mem.2002.129939
© 2002 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Annals of Emergency Medicine
Volume 40, Issue 6
, Pages 619-624
, December 2002
